The price reductions could also be a boon for Medicaidd, which spent nearly $160 million on Suboxone Film in 2018. (Photo: Shutterstock)
One of the most popular and effective treatments used to fight the U.S. opioid epidemic is about to get much cheaper.
Based in Hyderabad, a rambling boomtown in south India, Dr. Reddy's Laboratories Ltd. is a major supplier of generic drugs used by Americans for everything from infections to cardiovascular ailments. After a two-year legal battle, the company has won the right to sell a cheaper version of Suboxone Film, the best-selling opioid addiction drug in the U.S. too.
That victory will bring generic versions of the therapy to the U.S. nearly four years sooner than expected, helping cut into the bill for a drug that can cost about $500 a month at a recommended dose.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
